NVR C7 Pill - yellow round
Generic Name: alpelisib
Pill with imprint NVR C7 is Yellow, Round and has been identified as Vijoice 50 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Vijoice is used in the treatment of PIK3CA-Related Overgrowth Spectrum; Breast Cancer and belongs to the drug class PI3K inhibitors. Vijoice 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR C7
Vijoice
- Generic Name
- alpelisib
- Imprint
- NVR C7
- Strength
- 50 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- PI3K inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-1021
More about Vijoice (alpelisib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.